Vivimed Labs Ltd.
Snapshot View

View in App

Prices View details >>

6.67 ▼0%

27 March 2023, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vivimedlabs.com
Market Cap 55.30 Cr.
Enterprise Value(EV) 419.59 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -9.75 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 32.17 Trailing Twelve Months Ending 2022-12
Book Value / Share 31.81 Trailing Twelve Months Ending 2022-12
Price to Book Value 0.21 Calculated using Price: 6.67
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 8.29 Cr. 82,913,915 Shares
FaceValue 2
Company Profile
Vivimed Labs Ltd was originally incorporated as Emgi Pharmaceuticals & Chemicals Private Limited on 22-09-1988 with Registrar of Companies of Karnataka, Bangalore and subsequently converted into a public limited company on April 21, 1994. The name of the company has been changed to Vivimed Labs Limited on April 22,1997.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-4.99%
1 Month
-18.26%
3 Month
-40.50%
6 Month
-33.37%
1 Year
-55.83%
2 Year
-59.94%
5 Year
-90.61%
10 Year
-88.10%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 14.81 14.90 16.50 35.18 9.76 7.95 -20.75 -16.62 -18.80
Return on Capital Employed (%) 11.93 10.91 11.93 21.86 9.04 7.03 -2.69 -1.12 -3.54
Return on Assets (%) 3.90 3.86 4.25 10.44 3.43 2.44 -4.83 -4.13 -5.29

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 560 559 585 734 1,226 944 835 432 364 320
Non Curr. Liab. 533 538 561 504 357 490 591 517 528 534
Curr. Liab. 744 801 897 817 790 889 770 341 373 394
Minority Int. 12
Equity & Liab. 1,837 1,898 2,044 2,055 2,386 2,322 2,196 1,289 1,266 1,248
Non Curr. Assets 846 906 911 961 1,104 1,092 1,221 761 759 755
Curr. Assets 971 992 1,133 1,094 1,282 1,231 975 529 507 493
Misc. Exp. not W/O 20 0 0
Total Assets 1,837 1,898 2,044 2,055 2,386 2,322 2,196 1,289 1,266 1,248

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1,351 1,380 1,346 1,462 1,186 1,315 1,059 861 237 211
Other Income 36 8 24 8 24 34 12 10 1 1
Total Income 1,387 1,388 1,369 1,470 1,209 1,349 1,071 871 239 212
Total Expenditure -1,166 -1,158 -1,123 -1,057 -985 -1,146 -1,052 -830 -245 -235
PBIDT 220 230 247 413 224 203 19 42 -7 -23
Interest -67 -86 -85 -68 -82 -70 -61 -56 -40 -37
Depreciation -66 -66 -61 -58 -56 -67 -67 -55 -18 -17
Taxation -20 -5 -16 -73 -10 -9 0 -2 -3 -3
Exceptional Items
PAT 66 72 84 214 76 57 -109 -72 -68 -81
Minority Interest 2
Share Associate
Other Related Items
Consolidated Net Profit 66 72 84 214 78 57 -109 -72 -68 -81
Adjusted EPS 8 9 10 26 9 7 -13 -9 -8 -10

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 90 -118 140 154 58 21 422 80 567 28
Cash Fr. Inv. -170 -291 -107 -190 -68 -164 -89 -196 404 -16
Cash Fr. Finan. 67 419 -42 41 35 186 -338 72 -1,015 -10
Net Change -12 11 -8 4 25 44 -5 -44 -44 1
Cash & Cash Eqvt 24 35 27 31 55 99 95 50 6 7

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 32.79 28.57 28.57 28.57 28.57 21.98 20.96 20.96 20.96
Public 67.21 71.43 71.43 71.43 71.43 78.02 79.04 79.04 79.04
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 60.09 54.20 54.20 54.20 54.20 40.02 37.11 37.11 37.11

Announcements View Details >>

Tue, 28 Mar 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
Disclosure of Voting Results of the 34th Annual General Meeting held on 27th March 2023
Tue, 28 Mar 2023
Closure of Trading Window
Intimation of trading Window Closure
Mon, 27 Mar 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 34th Annual General Meeting (AGM) held on 27th March 2023

Technical Scans View Details >>

Mon, 27 Mar 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.37 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.66 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.90 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 7.53 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.77 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Vivimed Labs Ltd.

What is Vivimed Labs share price?
Can I buy Vivimed Labs shares now?
What is the Market Cap of Vivimed Labs?
What are the key metrics to analyse Vivimed Labs?
What is the 52 Week High and Low of Vivimed Labs?